Why Appen, Brainchip, Liontown, and Mesoblast shares are falling today
These shares are ending the week in the red. But why? The post Why Appen, Brainchip, Liontown, and Mesoblast shares are ...
Mesoblast After Approval: Stock Is Buoyant Now, But Unpredictable Overall
Mesoblast's FDA approval for remestemcel marks a milestone for MSC therapies, but limited cash reserves pose risks for US ...
Silent But Deadly: How Dormant Cancer Cells Fuel Breast Cancer Relapse
Dr. Gary Luker's study shows that breast cancer can lie dormant for years after treatment, especially in patients on estrogen ...
Pharmaceutical Technology5 天
Debamestrocel by BrainStorm Cell Therapeutics for Alzheimer’s Disease: Likelihood of Approval
Debamestrocel (NurOwn) was under development for the treatment of Coronavirus Disease 2019 (COVID-19), acute respiratory distress syndrome BrainStorm Cell Therapeutics, formerly Golden Hand Resources ...